Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients DURHAM, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the opening of its expanded non-commercial specialty pharmacy, FortreaRx™, located in

Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients DURHAM, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the opening of its expanded non-commercial specialty pharmacy, FortreaRx™, located in

Axi Select SYDNEY, Australia, Feb. 20, 2024 (GLOBE NEWSWIRE) — Bucking the trend of recent negative developments in the prop firm industry, leading global CFD and FX broker Axi, which launched Axi Select – their unique capital allocation programme for talented traders – has been hailed by many industry experts

POSSIBLE OFFER (RULE 2.4 ANNOUNCEMENT) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS IS AN ANNOUNCEMENT UNDER RULE 2.4 OF THE IRISH TAKEOVER PANEL ACT,

POSSIBLE OFFER (RULE 2.4 ANNOUNCEMENT) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS IS AN ANNOUNCEMENT UNDER RULE 2.4 OF THE IRISH TAKEOVER PANEL ACT,

As the CDP category reaches a maturity milestone, Tealium is recognized for its ability to execute and completeness of vision San Diego, Feb. 16, 2024 (GLOBE NEWSWIRE) — Tealium, the largest independent and most trusted customer data platform (CDP), today announced that it was named a Leader in the first-ever Gartner® Customer